Inventor
YAMNIUK AARON
US18 patents
⚠️ This page may combine multiple inventors who share the name “YAMNIUK AARON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
17 patentsUS9228018B2Jan 5, 2016
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO11 citations91
US8895010B2Nov 25, 2014
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO24 citations91
US11220550B2Jan 11, 2022
Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity
BRISTOL MYERS SQUIBB CO12 citations85
US11926673B2Mar 12, 2024
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO4 citations84
US11254750B2Feb 22, 2022
Antagonistic CD40 monoclonal antibodies and uses in treating immune responses
BRISTOL MYERS SQUIBB CO6 citations84
US9765150B2Sep 19, 2017
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO5 citations82
US8981072B2Mar 17, 2015
Nucleic acids encoding antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO8 citations82
US12419953B2Sep 23, 2025
Methods of treatment or prevention of immune responses and inflammatory diseases with antagonistic CD40 monoclonal antibodies
BRISTOL MYERS SQUIBB CO1 citations73
US11613585B2Mar 28, 2023
Nucleic acids encoding antagonistic CD40 monoclonal antibodies
BRISTOL MYERS SQUIBB CO3 citations72
US11795231B2Oct 24, 2023
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO2 citations71
US11773178B2Oct 3, 2023
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO2 citations71
US11261258B2Mar 1, 2022
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO2 citations71
US10196451B2Feb 5, 2019
Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L
BRISTOL MYERS SQUIBB CO1 citations71
US10544228B2Jan 28, 2020
Nucleic acids encoding antibody polypeptides that antagonize CD40
BRISTOL MYERS SQUIBB CO1 citations69
US12409223B2Sep 9, 2025
Antagonistic CD40 monoclonal antibodies and uses thereof
BRISTOL MYERS SQUIBB CO0 citations61
US11180567B2Nov 23, 2021
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO0 citations61
US11136406B2Oct 5, 2021
Methods of treating immune diseases by administering antibody polypeptides that antagonize CD40
BRISTOL MYERS SQUIBB CO0 citations59